person · Reporting owner

Coleman Glenn

Disclosed activity across 4 companies

Tapewire entity: 42512
SEC CIK: 0001434369

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398	EVP & Chief Financial Officer	September 30, 2026	October 03, 2026
DENTSPLY SIRONA Inc.XRAY · Entity 4448	Executive VP & CFO	October 11, 2024	October 15, 2024
INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707	Executive Vice President & COO	July 01, 2022	July 05, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Report date September 30, 2026 · Filed October 03, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	27,762	Reported balance After 2026-09-30 transaction · row 1 1 source row Row 1 · 2026-09-30 · Purchase · Acquired 10 · Balance 27,762 F1: The shares were acquired pursuant to the Company's Employee Stock Purchase Plan at the fair market value of the Company's common stock on the purchase date. The Reporting Person elected to participate in the Plan during an open trading window prior to the commencement of the quarterly purchase period.

Filing footnotes · ownership attribution and instrument terms

F1: The shares were acquired pursuant to the Company's Employee Stock Purchase Plan at the fair market value of the Company's common stock on the purchase date. The Reporting Person elected to participate in the Plan during an open trading window prior to the commencement of the quarterly purchase period.

DENTSPLY SIRONA Inc.

Report date October 11, 2024 · Filed October 15, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	89,767.654	Reported balance After 2024-10-11 transaction · row 1 1 source row Row 1 · 2024-10-11 · Grant · Acquired 375.279 · Balance 89,767.654 F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
Phantom Stock (Supplemental Executive Retirement Plan) SERPSEC Table II · derivative / convertible security	Direct	1,892.0687	Reported balance After 2024-10-11 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2024-10-11 · Grant · Acquired 12.2776 · Balance 1,892.0687 F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F3: Comprised of phantom stock acquired as a result of accrued dividends.

Filing footnotes · ownership attribution and instrument terms

F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment.

F3: Comprised of phantom stock acquired as a result of accrued dividends.

INTEGRA LIFESCIENCES HOLDINGS CORP

Report date July 01, 2022 · Filed July 05, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	34,622	Reported balance After 2022-07-01 transaction · row 1 1 source row Row 1 · 2022-07-01 · Tax withholding · Disposed 6,666 · Balance 34,622

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Premier, Inc.

Report date November 25, 2025 · Filed November 26, 2025

Section 16 reporting ended · disclosed 2025-11-26. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	0	Ending reported balance After 2025-11-25 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2025-11-25 · Disposition to issuer · Disposed 161,464 · Balance 32,018 F1: Reflects the disposition of shares of Class A Common Stock, par value $0.01 per share ("Common Stock") of Premier, Inc. ("Issuer") pursuant to the consummation of the transactions contemplated by the Agreement and Plan of Merger dated as of September 21, 2025 (the "Merger Agreement") by and among the Issuer, Premium Parent, LLC ("Parent") and Premium Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"). Pursuant to the Merger Agreement, at the effective time of the Merger on November 25, 2025 (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"). At the Effective Time, each issued and outstanding share of Common Stock was cancelled and converted automatically into the right to receive $28.25 in cash, without interest (the "Merger Consideration"), subject to certain exceptions set forth in the Merger Agreement. F2: The shares of the Issuer's Common Stock reported as disposed of by the reporting person include shares of Common Stock underlying outstanding time-based vesting restricted stock unit awards previously reported as beneficially owned by the reporting person ("RSUs") and granted to the reporting person prior to August 16, 2025. Pursuant to the Merger Agreement, at the Effective Time, each of these RSUs was cancelled and converted into the right to receive an amount in cash, without interest, equal to the number of shares of Common Stock subject to the RSUs multiplied by the Merger Consideration (together with any accrued cash dividend equivalents). Row 2 · 2025-11-25 · Disposition to issuer · Disposed 32,018 · Balance 0 F3: Reflects the cancellation at the Effective Time of RSUs granted to the reporting person on or after August 16, 2025. Pursuant to the Merger Agreement, these RSUs were cancelled in connection with the Merger for no consideration.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects the disposition of shares of Class A Common Stock, par value $0.01 per share ("Common Stock") of Premier, Inc. ("Issuer") pursuant to the consummation of the transactions contemplated by the Agreement and Plan of Merger dated as of September 21, 2025 (the "Merger Agreement") by and among the Issuer, Premium Parent, LLC ("Parent") and Premium Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"). Pursuant to the Merger Agreement, at the effective time of the Merger on November 25, 2025 (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"). At the Effective Time, each issued and outstanding share of Common Stock was cancelled and converted automatically into the right to receive $28.25 in cash, without interest (the "Merger Consideration"), subject to certain exceptions set forth in the Merger Agreement.

F2: The shares of the Issuer's Common Stock reported as disposed of by the reporting person include shares of Common Stock underlying outstanding time-based vesting restricted stock unit awards previously reported as beneficially owned by the reporting person ("RSUs") and granted to the reporting person prior to August 16, 2025. Pursuant to the Merger Agreement, at the Effective Time, each of these RSUs was cancelled and converted into the right to receive an amount in cash, without interest, equal to the number of shares of Common Stock subject to the RSUs multiplied by the Merger Consideration (together with any accrued cash dividend equivalents).

F3: Reflects the cancellation at the Effective Time of RSUs granted to the reporting person on or after August 16, 2025. Pursuant to the Merger Agreement, these RSUs were cancelled in connection with the Merger for no consideration.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
September 30, 2026 Filed Oct 3, 2026 00:27 UTC	CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398	PurchaseCommon Stock	10	$297.43	$2,974.30	Disclosure SEC source: 0001100682-26-000144 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,762 F1 · shares: The shares were acquired pursuant to the Company's Employee Stock Purchase Plan at the fair market value of the Company's common stock on the purchase date. The Reporting Person elected to participate in the Plan during an open trading window prior to the commencement of the quarterly purchase period. Read SEC document
May 29, 2026 Filed Jun 2, 2026 20:46 UTC	CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398	GrantCommon Stock	6,640	$180.71	$1,199,914.40	Disclosure SEC source: 0001100682-26-000101 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,752 F1 · shares: Unvested restricted stock units annually ratably vest on May 29, 2027; May 29, 2028; May 29, 2029; and May 29, 2030. Read SEC document
May 01, 2026 Filed May 4, 2026 21:16 UTC	CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398	GrantCommon Stock	21,112	$165.78	$3,499,947.36	Disclosure SEC source: 0001100682-26-000033 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,112 F1 · shares: Unvested restricted stock units annually ratably vest on: May 1, 2027; May 1, 2028; May 1, 2029; and May 1, 2030. Read SEC document
November 25, 2025 Filed Nov 26, 2025 15:45 UTC	Premier, Inc. PINC · Entity 72504	Disposition to issuerClass A Common Stock	32,018	$0.00	$0.00	Disclosure SEC source: 0001193125-25-299012 · ownership.xml · nonDerivative · entry 2 Coleman Glenn · CIK 0001434369 · CAO & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F3 · kind: Reflects the cancellation at the Effective Time of RSUs granted to the reporting person on or after August 16, 2025. Pursuant to the Merger Agreement, these RSUs were cancelled in connection with the Merger for no consideration. F3 · price: Reflects the cancellation at the Effective Time of RSUs granted to the reporting person on or after August 16, 2025. Pursuant to the Merger Agreement, these RSUs were cancelled in connection with the Merger for no consideration. Read SEC document
November 25, 2025 Filed Nov 26, 2025 15:45 UTC	Premier, Inc. PINC · Entity 72504	Disposition to issuerClass A Common Stock	161,464	$28.25	$4,561,358.00	Disclosure SEC source: 0001193125-25-299012 · ownership.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · CAO & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,018 F1 · kind: Reflects the disposition of shares of Class A Common Stock, par value $0.01 per share ("Common Stock") of Premier, Inc. ("Issuer") pursuant to the consummation of the transactions contemplated by the Agreement and Plan of Merger dated as of September 21, 2025 (the "Merger Agreement") by and among the Issuer, Premium Parent, LLC ("Parent") and Premium Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"). Pursuant to the Merger Agreement, at the effective time of the Merger on November 25, 2025 (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"). At the Effective Time, each issued and outstanding share of Common Stock was cancelled and converted automatically into the right to receive $28.25 in cash, without interest (the "Merger Consideration"), subject to certain exceptions set forth in the Merger Agreement. F2 · kind: The shares of the Issuer's Common Stock reported as disposed of by the reporting person include shares of Common Stock underlying outstanding time-based vesting restricted stock unit awards previously reported as beneficially owned by the reporting person ("RSUs") and granted to the reporting person prior to August 16, 2025. Pursuant to the Merger Agreement, at the Effective Time, each of these RSUs was cancelled and converted into the right to receive an amount in cash, without interest, equal to the number of shares of Common Stock subject to the RSUs multiplied by the Merger Consideration (together with any accrued cash dividend equivalents). F1 · price: Reflects the disposition of shares of Class A Common Stock, par value $0.01 per share ("Common Stock") of Premier, Inc. ("Issuer") pursuant to the consummation of the transactions contemplated by the Agreement and Plan of Merger dated as of September 21, 2025 (the "Merger Agreement") by and among the Issuer, Premium Parent, LLC ("Parent") and Premium Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"). Pursuant to the Merger Agreement, at the effective time of the Merger on November 25, 2025 (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"). At the Effective Time, each issued and outstanding share of Common Stock was cancelled and converted automatically into the right to receive $28.25 in cash, without interest (the "Merger Consideration"), subject to certain exceptions set forth in the Merger Agreement. F2 · price: The shares of the Issuer's Common Stock reported as disposed of by the reporting person include shares of Common Stock underlying outstanding time-based vesting restricted stock unit awards previously reported as beneficially owned by the reporting person ("RSUs") and granted to the reporting person prior to August 16, 2025. Pursuant to the Merger Agreement, at the Effective Time, each of these RSUs was cancelled and converted into the right to receive an amount in cash, without interest, equal to the number of shares of Common Stock subject to the RSUs multiplied by the Merger Consideration (together with any accrued cash dividend equivalents). Read SEC document
November 11, 2025 Filed Nov 12, 2025 20:53 UTC	Premier, Inc. PINC · Entity 72504	Tax withholdingClass A Common Stock	3,874	$28.17	$109,130.58	Disclosure SEC source: 0001193125-25-277429 · ownership.xml · nonDerivative · entry 2 Coleman Glenn · CIK 0001434369 · CAO & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,482 F1 · shares: Reflects the number of shares of the issuer's Common Stock that were withheld to cover tax liability in connection with vesting and settlement of stock unit grants reported on a prior Form 4. Read SEC document
November 11, 2025 Filed Nov 12, 2025 20:53 UTC	Premier, Inc. PINC · Entity 72504	Tax withholdingClass A Common Stock	17,026	$28.17	$479,622.42	Disclosure SEC source: 0001193125-25-277429 · ownership.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · CAO & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,356 F1 · shares: Reflects the number of shares of the issuer's Common Stock that were withheld to cover tax liability in connection with vesting and settlement of stock unit grants reported on a prior Form 4. Read SEC document
August 21, 2025 Filed Aug 22, 2025 17:11 UTC	Premier, Inc. PINC · Entity 72504	GrantClass A Common Stock	32,018	$0.00	$0.00	Disclosure SEC source: 0001434369-25-000003 · ownership.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · CAO & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,382 Read SEC document
August 19, 2025 Filed Aug 20, 2025 22:15 UTC	Premier, Inc. PINC · Entity 72504	GrantClass A Common Stock	23,888	$0.00	$0.00	Disclosure SEC source: 0000950170-25-110504 · ownership.xml · nonDerivative · entry 2 Coleman Glenn · CIK 0001434369 · CAO & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,364 F1 · shares: Represents Performance Share Awards allocated to the reporting person based on the issuer's fiscal year 2025 financial performance against fiscal year 2025 performance metrics for those awards, but which will not vest until after the end of a three year performance cycle subject to continued employment. Read SEC document
August 19, 2025 Filed Aug 20, 2025 22:15 UTC	Premier, Inc. PINC · Entity 72504	GrantClass A Common Stock	15,001	$0.00	$0.00	Disclosure SEC source: 0000950170-25-110504 · ownership.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · CAO & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,476 F1 · shares: Represents Performance Share Awards allocated to the reporting person based on the issuer's fiscal year 2025 financial performance against fiscal year 2025 performance metrics for those awards, but which will not vest until after the end of a three year performance cycle subject to continued employment. Read SEC document
November 11, 2024 Filed Nov 12, 2024 20:23 UTC	Premier, Inc. PINC · Entity 72504	GrantClass A Common Stock	143,475	$0.00	$0.00	Disclosure SEC source: 0000950170-24-125221 · ownership.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · CAO & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,475 Read SEC document
October 11, 2024 Filed Oct 15, 2024 20:30 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantPhantom Stock (Supplemental Executive Retirement Plan) SERP · Derivative	12.2776	$24.50	$300.80	Disclosure SEC source: 0001127602-24-025499 · form4.xml · derivative · entry 2 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,892.0687 Underlying: Common Stock · 12.2776 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. Read SEC document
October 11, 2024 Filed Oct 15, 2024 20:30 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	375.279	$0.00	$0.00	Disclosure SEC source: 0001127602-24-025499 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,767.654 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document
July 12, 2024 Filed Jul 15, 2024 20:40 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantPhantom Stock (Supplemental Executive Retirement Plan) SERP · Derivative	11.5859	$25.80	$298.92	Disclosure SEC source: 0001127602-24-020387 · form4.xml · derivative · entry 2 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,879.7911 Underlying: Common Stock · 11.5859 shares Expires not disclosed F3 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F3 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F3 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F4 · derivative.underlying_shares: Comprised of phantom stock acquired as a result of accrued dividends. Read SEC document
July 12, 2024 Filed Jul 15, 2024 20:40 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	404.918	$0.00	$0.00	Disclosure SEC source: 0001127602-24-020387 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,392.375 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F2 · balance_after: Includes 236 shares acquired between January 1st - June 30,2024 under the Dentsply Sirona Employee Stock Purchase Plan. Read SEC document
April 12, 2024 Filed Apr 15, 2024 23:13 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantPhantom Stock (Supplemental Executive Retirement Plan) SERP · Derivative	9.4552	$31.45	$297.37	Disclosure SEC source: 0001127602-24-012897 · form4.xml · derivative · entry 2 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,868.2052 Underlying: Common Stock · 9.4552 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F3 · shares: Comprised of phantom stock acquired as a result of accrued dividends. F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. Read SEC document
April 12, 2024 Filed Apr 15, 2024 23:13 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	302.443	$0.00	$0.00	Disclosure SEC source: 0001127602-24-012897 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,751.457 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document
March 18, 2024 Filed Mar 19, 2024 20:55 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantPhantom Stock (Supplemental Executive Retirement Plan) SERP · Derivative	1,858.75	$35.59	$66,152.91	Disclosure SEC source: 0001127602-24-010634 · form4.xml · derivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,858.75 Underlying: Common Stock · 1,858.75 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F2 · shares: Comprised of phantom stock. F3 · price: Supplemental Executive Retirement Plan (SERP) contribution for the year 2023 based on closing price on 12/29/2023. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment. Read SEC document
March 04, 2024 Filed Mar 6, 2024 21:33 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantStock Option (Right to Buy) · Derivative	62,800	$0.00 Strike: $33.28	$0.00	Disclosure SEC source: 0001127602-24-008823 · form4.xml · derivative · entry 2 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,800 Underlying: Common Stock · 62,800 shares Expires 2034-03-04 F2 · derivative.exercise_date: Stock options vest in annual one-third (1/3) increments over a three (3) year period ending March 4, 2027. Read SEC document
March 04, 2024 Filed Mar 6, 2024 21:33 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	18,780	$0.00	$0.00	Disclosure SEC source: 0001127602-24-008823 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,449.014 F1 · shares: Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending 3/4/2027. Read SEC document
March 01, 2024 Filed Mar 4, 2024 22:55 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	Tax withholdingCommon Stock	1,683	$33.27	$55,993.41	Disclosure SEC source: 0001127602-24-008222 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,669.014 F1 · shares: Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I. Read SEC document
January 12, 2024 Filed Jan 16, 2024 18:45 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	193.629	$0.00	$0.00	Disclosure SEC source: 0001127602-24-001307 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,352.014 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F2 · balance_after: Includes 165 shares acquired between July 1st - December 31, 2023 under the Dentsply Sirona Employee Stock Purchase Plan. Read SEC document
November 22, 2023 Filed Nov 27, 2023 21:28 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	Tax withholdingCommon Stock	2,461	$31.36	$77,176.96	Disclosure SEC source: 0001127602-23-028287 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,105.385 F1 · shares: Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I. Read SEC document
November 20, 2023 Filed Nov 20, 2023 21:10 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	PurchaseCommon Stock	10,000	$29.70	$297,000.00	Disclosure SEC source: 0001127602-23-027984 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,566.385 Read SEC document
November 15, 2023 Filed Nov 16, 2023 21:25 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	Tax withholdingCommon Stock	2,385	$29.32	$69,928.20	Disclosure SEC source: 0001127602-23-027596 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,566.385 F1 · shares: Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I. Read SEC document
October 13, 2023 Filed Oct 16, 2023 20:46 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	268.072	$0.00	$0.00	Disclosure SEC source: 0001127602-23-025907 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,951.385 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document
July 14, 2023 Filed Jul 17, 2023 20:54 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	228.02	$0.00	$0.00	Disclosure SEC source: 0001127602-23-020823 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,683.313 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F2 · balance_after: Includes 86 shares acquired between January 1st - June 30, 2023 under the Dentsply Sirona Employee Stock Purchase Plan. Read SEC document
April 14, 2023 Filed Apr 18, 2023 20:36 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	231.492	$0.00	$0.00	Disclosure SEC source: 0001127602-23-013135 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,369.293 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document
March 03, 2023 Filed Mar 7, 2023 21:09 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantStock Option (Right to Buy) · Derivative	49,700	$0.00 Strike: $38.74	$0.00	Disclosure SEC source: 0001127602-23-009277 · form4.xml · derivative · entry 2 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,700 Underlying: Common Stock · 49,700 shares Expires 2033-03-03 F2 · derivative.exercise_date: Stock Options vest in annual one-third (1/3) increments over a three (3) year period ending March 3, 2026. Read SEC document
March 03, 2023 Filed Mar 7, 2023 21:09 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	16,133	$0.00	$0.00	Disclosure SEC source: 0001127602-23-009277 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,137.801 F1 · kind: Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending March 3, 2026. Read SEC document
January 13, 2023 Filed Jan 13, 2023 21:36 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	378.801	$0.00	$0.00	Disclosure SEC source: 0001127602-23-001395 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,004.801 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document
November 22, 2022 Filed Nov 23, 2022 15:32 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	24,695	$0.00	$0.00	Disclosure SEC source: 0001127602-22-026304 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,626 F1 · shares: Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending November 22, 2025. Read SEC document
November 15, 2022 Filed Nov 17, 2022 21:19 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantStock Option (Right to Buy) · Derivative	74,600	$0.00 Strike: $31.34	$0.00	Disclosure SEC source: 0001127602-22-025939 · form4.xml · derivative · entry 2 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,600 Underlying: Common Stock · 74,600 shares Expires 2032-11-15 F2 · derivative.exercise_date: Stock Options vest in annual one-third (1/3) increments over a three-year period ending November 15, 2025. Read SEC document
November 15, 2022 Filed Nov 17, 2022 21:19 UTC	DENTSPLY SIRONA Inc. XRAY · Entity 4448	GrantCommon Stock	23,931	$0.00	$0.00	Disclosure SEC source: 0001127602-22-025939 · form4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,931 F1 · kind: Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending November 15, 2025. Read SEC document
July 01, 2022 Filed Jul 5, 2022 20:57 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	Tax withholdingCommon Stock	6,666	$55.00	$366,630.00	Disclosure SEC source: 0001209191-22-040765 · doc4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,622 Read SEC document
April 04, 2022 Filed Apr 6, 2022 20:17 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	SaleCommon Stock	6,268	$66.04	$413,938.72	Disclosure SEC source: 0001209191-22-023469 · doc4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,288 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F1 · acquired: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document
March 13, 2022 Filed Mar 15, 2022 20:46 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	Tax withholdingCommon Stock	5,338	$65.11	$347,557.18	Disclosure SEC source: 0001209191-22-018845 · doc4.xml · nonDerivative · entry 8 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,556 Read SEC document
March 13, 2022 Filed Mar 15, 2022 20:46 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	Tax withholdingCommon Stock	2,902	$65.11	$188,949.22	Disclosure SEC source: 0001209191-22-018845 · doc4.xml · nonDerivative · entry 7 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,894 Read SEC document
March 13, 2022 Filed Mar 15, 2022 20:46 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	Tax withholdingCommon Stock	1,424	$65.11	$92,716.64	Disclosure SEC source: 0001209191-22-018845 · doc4.xml · nonDerivative · entry 6 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55.796 Read SEC document
March 13, 2022 Filed Mar 15, 2022 20:46 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	Tax withholdingCommon Stock	775	$65.11	$50,460.25	Disclosure SEC source: 0001209191-22-018845 · doc4.xml · nonDerivative · entry 5 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,220 Read SEC document
March 12, 2022 Filed Mar 15, 2022 20:46 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	Tax withholdingCommon Stock	1,770	$65.11	$115,244.70	Disclosure SEC source: 0001209191-22-018845 · doc4.xml · nonDerivative · entry 4 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,995 Read SEC document
March 12, 2022 Filed Mar 15, 2022 20:46 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	Tax withholdingCommon Stock	3,706	$65.11	$241,297.66	Disclosure SEC source: 0001209191-22-018845 · doc4.xml · nonDerivative · entry 3 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,765 Read SEC document
March 12, 2022 Filed Mar 15, 2022 20:46 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	Tax withholdingCommon Stock	1,107	$65.11	$72,076.77	Disclosure SEC source: 0001209191-22-018845 · doc4.xml · nonDerivative · entry 2 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,471 Read SEC document
March 11, 2022 Filed Mar 15, 2022 20:46 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantNon-Qualified Stock Option (right to buy) · Derivative	20,023	$0.00 Strike: $65.11	$0.00	Disclosure SEC source: 0001209191-22-018845 · doc4.xml · derivative · entry 9 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,023 Underlying: Common Stock · 20,023 shares Expires 2030-03-11 F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2022. F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2022. Read SEC document
March 11, 2022 Filed Mar 15, 2022 20:46 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	7,119	$0.00	$0.00	Disclosure SEC source: 0001209191-22-018845 · doc4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,578 Read SEC document
February 11, 2022 Filed Feb 14, 2022 21:47 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	12,576	$0.00	$0.00	Disclosure SEC source: 0001209191-22-009337 · doc4.xml · nonDerivative · entry 3 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,459 F4 · shares: On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 12, 2021 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2022 at 200% of target, the first anniversary of the grant date. Read SEC document
February 11, 2022 Filed Feb 14, 2022 21:47 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	10,837	$0.00	$0.00	Disclosure SEC source: 0001209191-22-009337 · doc4.xml · nonDerivative · entry 2 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,883 F3 · shares: On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2020 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2022 at 150% of target, the second anniversary of the grant date. Read SEC document
February 11, 2022 Filed Feb 14, 2022 21:47 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	GrantCommon Stock	5,892	$0.00	$0.00	Disclosure SEC source: 0001209191-22-009337 · doc4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,046 F1 · shares: On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2019 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2022 at 150% of target, the third anniversary of the grant date. F2 · balance_after: Includes 373 shares acquired under the Integra Employee Stock Purchase Plan since the date of the reporting person's most recent filing on Form 4. Read SEC document
November 02, 2021 Filed Nov 3, 2021 20:48 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	SaleCommon Stock	4,275	$74.00	$316,350.00	Disclosure SEC source: 0001209191-21-062723 · doc4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,781 F1 · kind: The transaction reported in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document
April 16, 2021 Filed Apr 19, 2021 20:19 UTC	INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707	Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative	25,658	$0.00 Strike: $19.41	$0.00	Disclosure SEC source: 0001209191-21-027283 · doc4.xml · derivative · entry 3 Coleman Glenn · CIK 0001434369 · Executive Vice President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,658 shares Expires 2022-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · derivative.exercise_date: 25% of the stock options vested every first, second, third and fourth anniversaries of the grant date of 5/2/2014. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.